A 73-Year-Old Woman with Episodic Dysarthria and Horizontal Binocular Diplopia
Neurol 98:767-772, Bower, A.S.,et al, 2022
Morvan Syndrome as a Paraneoplastic Disorder of Thymoma with Anti-CASPR2 antibodies
Lancet 389:1367-1368, Vale, T.C.,et al, 2017
Morvan Syndrome: Clinical and Serological Observations in 29 Cases
Ann Neurol 72:241-255, Irani, S.R.,et al, 2012
Primary Episodic Ataxias:Diagnosis, Pathogenesis and Treatment
Brain 130:2484-2493, Jen, J.C.,et al, 2007
Levetiracetam in the Treatment of Idiopathic Hemifacial Spasm
Neurol 62:2134-2135, Deleu,D., 2004
Drug Treatments for Eye Movement Disorders
JNNP 74:1-4, Leigh,R.J., &Tomsak,R.L., 2003
Botulinum Toxin A Treatment for Primary Hemifacial Spasm
Arch Neurol 59:418-420, Defazio,G.,et al, 2002
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
Long Term Results of Botulinum Toxin Type A (Dysport) in the Treatment of Hemifacial Spasm:A Report of 175 Cases
JNNP 64:751-757, Jitpimolmard,S.,et al, 1998
Hemifacial Spasm:Clinical Findings and Treatment
Muscle & Nerve 21:1740-1747, Wang,A & Jankovic,J, 1998
Morvan's Fibrillary Chorea: A Paraneoplastic Manifestation of Thymoma
JNNP 65:857-862, Lee,E.K.,et al, 1998
Post-Irradation Neuromyotona Affecting Trigeminal Nerve Distribution:An Unusual Presentation
Neurol 42:1102-1104, Diaz,J.M.,et al, 1992
Botulinum Toxin, Useful in Adult Onset Focal Dystonias
BMJ 305:1169-1170, Lees,A.J., 1992
Treatment of Hemifacial Spasm with Botulinum Toxin
Muscle & Nerve 15:1045-1049992., Yoshimura,D.M.,et al, 1992
Therapeutic Uses Of Botulinum Toxin
NEJM 324:1186-1194, Jankovic,J.&Brin,M.F., 1991
Cramp-Fasciculation Syndrome:A Treatable Hyperexcitable Peripheral Nerve Disorder
Neurol 41:1021-1024, Tahmoush,A.J.,et al, 1991
Autoimmune Aetiology for Acquired Neuromyotonia (Isaacs'Syndrome)
Lancet 338:75-77, Sinha,S.,et al, 1991
Clinical Use of Botulinum Toxin
National Institutes of Health Consensus Develop Conf Stmt, Nov 12-14, 1990, Arch Neurol 48:1294-1298, 199, 1991
Botulinum Toxin Treatment of Cranial-Cervical Dystonia, Spasmodic Dystonia, Focal Dystonias & Hemifacial Spasm
JNNP 53:633-639, Jankovic,J.,et al, 1990
Assessment:The Clinical Usefulness of Botulinum Toxin-A in Treating Neurologic Disorders
Subcommittee Report, Neurol 40:1332-13361990., , 1990
Hemifacial Spasm in Rochester & Olmsten County, Minnesota, 1960-21984
Arch Neurol 47:1233-1234, Auger,R.G.&Whisnant,J.P., 1990
Blepharospasm, Meige Syndrome, & Hemifacial Spasm:Treatment with Botulinum Toxin
Neurol 35:1499-1500, Mauriello,J.A., 1985
Pathophysiology of Hemifacial Spasm:III, Effects of Facial Nerve Decompression
Neurol 34:891-897, Nielsen,V.K.,et al, 1984
Carbamazepine for Hemifacial Spasm
Neurol 32:286-287, Alexander,G.E.,et al, 1982
Hemifacial Spasm; A Long Term Follow-up of Patients Treated by Posterior Fossa Surgery & Facial Nerve Wrapping
JNNP 44:1100-1103, Kaye,A.H.,et al, 1981
Neurologic Disturbances in Pagets Disease of Bone:Response to Calcitonin
Neurol 29:448-457, Chen,J.R.,et al, 1979
Isaac Syndrome with Laryngeal Involvement:An Unusual Presentation of Myokymia
Neurol 29:1612-1615, Jackson,D.L.,et al, 1979
Hemifacial Spasm
Arch Neurol 35:481, Maroon,J.C., 1978